| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |